日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810

帕唑帕尼与安慰剂治疗转移性肾细胞癌患者(转移灶切除术后无疾病证据)的随机、双盲 III 期研究:ECOG-ACRIN E2810

Appleman, Leonard J; Kim, Se Eun; Harris, Wayne B; Pal, Sumanta K; Pins, Michael R; Kolesar, Jill; Agarwal, Neeraj; Parikh, Rahul A; Vaena, Daniel A; Ryan, Christopher W; Hashmi, Mehmood; Costello, Brian A; Cella, David; Dutcher, Janice P; DiPaola, Robert S; Haas, Naomi B; Wagner, Lynne I; Carducci, Michael A

Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer

循环肿瘤细胞计数与转移性激素敏感性前列腺癌患者的总生存期

Goldkorn, Amir; Tangen, Catherine; Plets, Melissa; Bsteh, Daniel; Xu, Tong; Pinski, Jacek K; Ingles, Sue; Triche, Timothy Junius; MacVicar, Gary R; Vaena, Daniel A; Crispino, Anthony W; McConkey, David James; Lara, Primo N Jr; Hussain, Maha H A; Quinn, David I; Dorff, Tanya B; Lerner, Seth Paul; Thompson, Ian Jr; Agarwal, Neeraj

Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)

Orteronel治疗转移性激素敏感性前列腺癌:一项多中心、随机、开放标签的III期试验(SWOG-1216)

Agarwal, Neeraj; Tangen, Catherine M; Hussain, Maha H A; Gupta, Shilpa; Plets, Melissa; Lara, Primo N; Harzstark, Andrea L; Twardowski, Przemyslaw W; Paller, Channing J; Zylla, Dylan; Zibelman, Matthew R; Levine, Ellis; Roth, Bruce J; Goldkorn, Amir; Vaena, Daniel A; Kohli, Manish; Crispino, Tony; Vogelzang, Nicholas J; Thompson, Ian M Jr; Quinn, David I

Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216)

基线循环肿瘤细胞计数作为转移性去势敏感性前列腺癌PSA反应和疾病进展的预后标志物(SWOG S1216)

Goldkorn, Amir; Tangen, Catherine; Plets, Melissa; Morrison, Gareth J; Cunha, Alexander; Xu, Tong; Pinski, Jacek K; Ingles, Sue A; Triche, Timothy; Harzstark, Andrea L; Kohli, Manish; MacVicar, Gary R; Vaena, Daniel A; Crispino, Anthony W; McConkey, David J; Lara, Primo N Jr; Hussain, Maha H A; Quinn, David I; Vogelzang, Nicholas J; Thompson, Ian Murchie Jr; Agarwal, Neeraj

Plasma angiopoietin 2 concentrations are related to impaired lung function and organ failure in a clinical cohort receiving high-dose interleukin 2 therapy.

在接受高剂量白细胞介素 2 治疗的临床队列中,血浆血管生成素 2 浓度与肺功能受损和器官衰竭有关

Gores Kathryn M, Delsing Angela S, Kraus Sara J, Powers Linda, Vaena Daniel A, Milhem Mohammed M, Monick Martha, Doerschug Kevin C

Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206

贝伐珠单抗联合干扰素α与干扰素α单药治疗转移性肾细胞癌患者的III期试验:CALGB 90206的最终结果

Rini, Brian I; Halabi, Susan; Rosenberg, Jonathan E; Stadler, Walter M; Vaena, Daniel A; Archer, Laura; Atkins, James N; Picus, Joel; Czaykowski, Piotr; Dutcher, Janice; Small, Eric J

Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206

贝伐珠单抗联合干扰素α与干扰素α单药治疗转移性肾细胞癌患者的疗效比较:CALGB 90206

Rini, Brian I; Halabi, Susan; Rosenberg, Jonathan E; Stadler, Walter M; Vaena, Daniel A; Ou, San-San; Archer, Laura; Atkins, James N; Picus, Joel; Czaykowski, Piotr; Dutcher, Janice; Small, Eric J